In accordance with the Ministry of Food and Drug Safety's 'Correction of Product Approval Change Order' (Drug Management Division-No. 1652, effective date 2013.5.21), there are corrections to the precautions for use of Atodipine tablets in the change order dated May 6, 2013.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Atodipin Tab.
Attachments are original documents and may be in Korean. English editions are labeled separately.
Change order for permission information_Atodipine tablet (correction).hwpChange order for permission information_Atodipine tablet (correction).hwp · 100 KBDownload ↓